Don't Automatically Substitute Remsima or Inflectra for Remicade

You'll soon see two new versions of infliximab called Remsima (REM-see-muh) and Inflectra (in-FLEC-truh).

They will be used as alternatives to Remicade...but they're NOT considered generics. Instead, they're called biosimilars...or subsequent entry biologics (SEBs).

That's because infliximab and other biologics are made from cells of living organisms and cannot be exactly duplicated.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote